Free preview. Sign up free to see investors, shareholders, financials, and full round details.
KYMAB LIMITED
ACTIVEKymab Limited develops fully human monoclonal antibodies for the treatment of inflammatory diseases, Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du Sign up to read more
- Company number
- 07027523
- Incorporated
- 2009-09-23
- Last updated
- 1 Jul 2026
- Registered office
- THE EDDEVA BUILDING (B920), BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT, ENGLAND
- SIC
- 74909
Profile updated Jul 2026